Botanical species · safety record
Carapichea ipecacuanha
The EFSA Compendium of Botanicals holds 3 constituent measurements and 5 adverse-effect records for Carapichea ipecacuanha. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Carapichea ipecacuanha (Brot.) L.Andersson
Also recorded as
Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 2 licensed products naming Carapichea ipecacuanha as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Source material stated
What the records describe
Constituents measured
- Emetine2
- Cephaeline1
Plant parts
- Roots and other underground parts3
Effect types
- Pulmonary and cardiac3
- Digestive1
- Neurotoxicity1
Target tissues
- Heart3
- Digestive1
- Neurologic: central nervous system1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Cephaeline | Roots and other underground parts | — | — | — | No resolvable identifier |
| Emetine | Roots and other underground parts | — | — | — | No resolvable identifier |
| Emetine | Roots and other underground parts | — | — | — | No resolvable identifier |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Digestive | Digestive | — | — | Human (as organism) | Case report | No resolvable identifier |
| Neurotoxicity | Neurologic: central nervous system | — | — | Human (as organism) | Case report | No resolvable identifier |
| Pulmonary and cardiac | Heart | — | — | — | Case report | No resolvable identifier |
| Pulmonary and cardiac | Heart | — | — | Human (as organism) | Case report | No resolvable identifier |
| Pulmonary and cardiac | Heart | — | — | Human (as organism) | Case report | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Ho P C., Dweik R., Cohen M C. Rapidly reversible cardiomyopathy associated with chronic ipecac ingestion. Clinical cardiology, 1998, p. 780-783.
- Gordon G. Ipecacuahana induced emesis in the treatment of self-poisoned adults. Archives of emergency medicine, 1985, p. 203-208.
- Friedman E J. Death from ipecac intoxication in a patient with anorexia nervosa. The american journal of psychiatry, 1984, p. 702-703.
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.